Document:

Prepared by MERRILL CORPORATION

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.1    
  

UNITEDHEALTH GROUP INCORPORATED

$400,000,000 5.20% Notes due January 17, 2007

Officers' Certificate and Company Order  

        Pursuant to the senior debt securities Indenture dated as of November 15, 1998, as amended by an Amendment to Indenture dated November 6, 2000
(collectively, the "Indenture"), between UnitedHealth Group Incorporated, a Minnesota corporation (the "Company"), and The Bank of New York, as Trustee (the "Trustee") and resolutions adopted by the
Company's Board of Directors on May 9, 2001, this Officers' Certificate and Company Order is being delivered to the Trustee to establish the terms of a series of Securities in accordance with
Section 301 of the Indenture, to establish the form of the Securities of such series in accordance with Section 201 of the Indenture, to request the authentication and delivery of the
Securities of such series pursuant to Section 303 of the Indenture and to comply with the provisions of Section 104 of the Indenture. This Officers' Certificate and Company Order shall
be treated for all purposes under the Indenture as a supplemental indenture thereto. 

        All
conditions precedent provided for in the Indenture relating to (i) the establishment of a series of Securities, (ii) the establishment of the form of Securities of such
series and (iii) the procedures for authentication and delivery of such series of securities have been complied with. 

        Capitalized
terms used herein and not otherwise defined herein shall have the meanings assigned to them in the Indenture. 

        A.    Establishment of a series of Securities pursuant to Section 301 of the Indenture.

        There
is hereby established pursuant to Section 301 of the Indenture a series of Securities which shall have the following terms: 

        (1)  The
Securities shall bear the title "5.20% Notes due January 17, 2007" (referred to herein as the "Notes"). 

        (2)  The
aggregate principal amount of the Notes to be issued pursuant to this Officers' Certificate and Company Order shall be limited to $400,000,000 except for
(a) Notes authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Notes pursuant to Section 304, 305, 306, 1007 or 1205 of the Indenture,
(b) Notes which, pursuant to Section 303 of the Indenture, are deemed never to have been authenticated and delivered thereunder and (c) any Securities of this series which are
issued in the manner contemplated by paragraph 18 hereof. 

        (3)  Interest
will be payable to the Person in whose name a Note (or any Predecessor Security) is registered at the close of business on the Regular Record Date (as defined
below) immediately preceding each Interest Payment Date (as defined below). In the event that a payment of principal or interest is due on a date that is not a Business Day (as defined below), the
related payment of principal or interest shall be made on the next succeeding Business Day with the same force and effect as if made on the date such payment was due, and no interest shall accrue on
the amount so payable for the period from and after such Interest Payment Date or date of Maturity, as the case may be. "Business Day" shall mean any day other than a Saturday, a Sunday or a legal
holiday in The City of New York on which banking institutions are authorized or required by law, regulation or executive order to close. 

        (4)  The
Stated Maturity Date of the Notes shall be January 17, 2007. 

        (5)  (A)    The
Notes shall bear interest at the rate of 5.20% per annum (based upon a 360-day year of twelve 30-day months), from
January 17, 2002 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, as the case may be, payable semi-annually on July 17 and
January 17 in each year, commencing July 17, 2002, until the 

 

principal
thereof is paid or made available for payment. Each such July 17 and January 17 shall be an "Interest Payment Date" for the Notes, and each July 2 and January 2
(whether or not a Business Day), as the case may be, immediately preceding an Interest Payment Date for the Notes shall be the "Regular Record Date" for the interest payable on such Interest Payment
Date. 

        (B)  The
provision related to interest on overdue principal in Section 501 of the Indenture shall not be applicable to the Notes. 

        (6)  Principal
of (and premium, if any) and interest on the Notes will be payable, and, except as provided in Section 305 of the Indenture with respect to a Global
Security (as defined below), the transfer of the Notes will be registrable and Notes will be exchangeable for Notes bearing identical terms and provisions at the corporate trust office of The Bank of
New York, in the City of New York, New York, provided, however, that payment of principal or interest
may be made at the option of the Company by check mailed to the Person entitled thereto as shown on the Security Register. 

        (7)  The
Notes will be redeemable as follows: 

        The
Notes will be subject to redemption, in whole or in part at any time before their Stated Maturity, at the option of the Company at a Redemption Price equal to the greater of
(i) 100% of the principal amount of the Notes to be redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and interest on the Notes to be
redeemed (excluding the portion of any such interest accrued to the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year
consisting of twelve 30-day months) at the Treasury Yield (as defined below), plus 25 basis points, plus, in each case, accrued and unpaid interest to the Redemption Date. For this
purpose, the following terms have the following meanings: 

	•
	"Treasury
Yield" means, with respect to any Redemption Date, the rate per year equal to the semi-annual equivalent yield to maturity or
interpolated (on a day count basis) yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to
the Comparable Treasury Price for such Redemption Date.

	•
	"Comparable
Treasury Issue" means, the United States Treasury security selected by an Independent Investment Banker appointed by the Trustee after
consultation with the Company as having an actual or interpolated maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes.

	•
	"Comparable
Treasury Price" means, with respect to any Redemption Date, (i) the average of the Reference Treasury Dealer Quotations for such
Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations for such Redemption Date, or (ii) if the Trustee obtains fewer than four such Reference
Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations.

	•
	"Independent
Investment Banker" means either Goldman, Sachs & Co. or Merrill Lynch, Pierce, Fenner & Smith Incorporated or their respective
successors or, if such firms are unwilling or unable to select the Comparable Treasury Issue, one of the remaining Reference Treasury Dealers appointed by the Trustee after consultation with the
Company.

	•
	"Reference
Treasury Dealer" means (i) each of Goldman, Sachs & Co. and Merrill Lynch, Pierce, Fenner & Smith Incorporated or their
affiliates and any other primary U.S. Government securities dealer in New York City (a "Primary Treasury Dealer") designated by, and not 

2

 

affiliated
with, either Goldman, Sachs & Co. or Merrill Lynch, Pierce, Fenner & Smith Incorporated, provided,  however, that if Goldman,
Sachs & Co. or Merrill Lynch, Pierce, Fenner & Smith Incorporated or any of their respective affiliates shall
cease to be a Primary Treasury Dealer, the Company will appoint another Primary Treasury Dealer as a substitute for such entity and (ii) any other Primary Treasury Dealer selected by the
Trustee. 

	•
	"Reference
Treasury Dealer Quotations" means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the
Company, of the bid and asked prices for the Comparable Treasury Issue (expressed, in each case, as a percentage of its principal amount) quoted in writing to the Trustee by such Reference Treasury
Dealer at 5:00 p.m. on the third business day preceding such Redemption Date. 

        A
notice of redemption may provide that it is subject to certain conditions that will be specified in the notice. If those conditions are not met, the redemption notice will be of no
effect and the Company will not be obligated to redeem the Notes. 

        A
partial redemption of the Notes may be effected on a pro rata basis (and in such manner as complies with applicable legal and stock exchange requirements, if any) or in such method as
the Trustee, in the exercise of its reasonable discretion, deems fair and appropriate. The trustee may provide for the selection for redemption of portions in amounts of $1,000 or whole multiples of
$1,000; except that if all of the Notes of a Holder are to be redeemed, the entire outstanding amount of Notes held by such Holder, even if not a multiple of $1,000, shall be redeemed. 

        Notice
of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed. 

        Unless
any Note called for redemption shall not be paid upon surrender thereof for redemption, on and after the Redemption Date interest will cease to accrue on the Notes or portions
thereof called for redemption. 

        (8)  The
Company shall not be obligated to redeem or purchase any Notes pursuant to any sinking fund or analogous provisions or at the option of the Holder. 

        (9)  The
Notes shall not be convertible into shares of Common Stock of the Company or exchangeable for any other securities. 

      (10)  The
Trustee shall be the Security Registrar and the Paying Agent. 

      (11)  The
amount of payments of principal of and any premium or interest on the Notes will not be determined with reference to an index. 

      (12)  The
Notes shall be subject to the covenants and definitions set forth in the Indenture. 

      (13)  The
Notes will be issued only in fully registered form and the minimum initial purchase amounts of the Notes shall be $1,000 and any integral multiple of $1,000 in
excess thereafter. 

      (14)  The
Notes shall be subject to the Events of Default specified in Section 701, paragraphs (i) through (viii), of the Indenture. 

      (15)  The
portion of the principal amount of the Notes which shall be payable upon declaration of acceleration of maturity thereof shall not be less than the principal amount
thereof. 

      (16)  The
Notes will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as Depositary, and will be represented by a global security (a
"Global Security") registered in the name of a nominee of the Depositary. So long as the Depositary or its nominee is the registered holder of any Global Security, the Depositary or its nominee, as
the case may be, will be considered the sole Holder of the Notes represented by such Global Security for all purposes under the Indenture and the Notes. 

3

 

      (17)  The
defeasance provisions set forth in Sections 902 and 903 of the Indenture shall apply to the Notes. 

      (18)  The
Company may, so long as no Event of Default has occurred, without the consent of the Holders of the Notes, issue additional notes with the same terms as the Notes
in accordance with the corporate authority existing at the time of such additional issuance, and such additional notes shall be
considered part of the same series under the Indenture as the Notes. The Notes shall have such other terms and provisions as are provided in the Global Security representing the Notes substantially in
the form attached as Exhibit A hereto. 

      (19)  The
CUSIP number for the Notes is 91324P AD 4. 

        B.    Establishment of Forms of Securities Pursuant to Section 201 of Indenture.

        It
is hereby established pursuant to Section 201 of the Indenture that the Global Security representing the Notes shall be substantially in the form attached as Exhibit A
hereto. 

        C.    Order for the Authentication and Delivery of Securities Pursuant to Section 303 of the Indenture.

        It
is hereby ordered pursuant to Section 303 of the Indenture that the Trustee authenticate, in the manner provided by the Indenture, the Notes in the aggregate principal amount
of $400,000,000 registered in the name of Cede & Co., which Notes have been heretofore duly executed by the proper officers of the Company and delivered to you as provided in the Indenture, and
to deliver said authenticated Notes to or on behalf of The Depository Trust Company on or before 9:00 a.m., Eastern Standard Time, on January 17, 2002. 

        D.    Other Matters.

        Attached
as Exhibit B hereto are true and correct copies of resolutions adopted by the Board of Directors of the Company at a meeting on May 9, 2001; such resolutions have
not been further amended, modified or rescinded and remain in full force and effect; and such resolutions (together with this Officers' Certificate and Company Order) are the only resolutions or other
action adopted by the Company's Board of Directors or any committee thereof or by any officers of the Company relating to the offering and sale of the Notes. 

        The
undersigned Chief Financial Officer being an Authorized Representative as defined in the resolutions of the Board of Directors of the Company adopted at a meeting on May 9,
2001 certifies that (i) he has approved the terms of the Notes as set forth in this Officers' Certificate and Company Order, (ii) he has approved and ratified the terms and form of the
Underwriting Agreement dated January 14, 2002 and the Pricing Agreement dated January 14, 2002 (the "Pricing Agreement") between the Company and Goldman, Sachs & Co. and Merrill
Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the several Underwriters named in Schedule I to the Pricing Agreement and (iii) he
has approved and ratified the Indenture, all in accordance with the authority of such officer pursuant to such resolutions. 

        The
undersigned have read the pertinent sections of the Indenture including the related definitions contained therein. The undersigned have examined the resolutions adopted by the Board
of Directors of the Company. In the opinion of the undersigned, the undersigned have made such examination or investigation as is necessary to enable the undersigned to express an informed opinion as
to whether or not the conditions precedent to (i) the establishment of the Notes, (ii) the establishment of the forms of the Notes and (iii) the authentication of the Notes,
contained in the Indenture have been complied with. In the opinion of the undersigned, such conditions have been complied with. 

        Faegre &
Benson LLP and Dorsey & Whitney LLP are entitled to rely on this Officers' Certificate and Company Order in connection with the opinion they are rendering pursuant
to Sections 7(b) and 7(c), respectively, of the Underwriting Agreement. 

4

 

        IN
WITNESS WHEREOF, the undersigned have executed this Officers' Certificate and Company Order this 17th day of January, 2002. 

	 	 	UNITEDHEALTH GROUP INCORPORATED
	

 	
 	

 
	 	 	/s/ Patrick J. Erlandson
	 	 	
 Patrick J. Erlandson
 Chief Financial Officer
	

 	
 	

/s/ David J. Lubben
	 	 	
 David J. Lubben
 General Counsel and Secretary

5

QuickLinks

Exhibit 4.1Prepared by MERRILL CORPORATION

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.2    
  

        THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE SENIOR DEBT SECURITIES INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY
(AS DEFINED IN THE INDENTURE) OR A NOMINEE THEREOF. THIS NOTE IS EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES
DESCRIBED IN THE INDENTURE AND, UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF
THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. 

        UNLESS
THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION, TO THE COMPANY (AS DEFINED BELOW) OR TO ITS AGENT FOR REGISTRATION
OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY
PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

	REGISTERED	 	UNITEDHEALTH GROUP

INCORPORATED	 	$400,000,000

CUSIP
	No. 1	 	5.20% Notes due January 17, 2007	 	No. 91324P AD 4

        UNITEDHEALTH GROUP INCORPORATED, a Minnesota corporation (hereinafter called the "Company", which term includes any successor corporation
under the Indenture referred to below), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of FOUR HUNDRED MILLION
DOLLARS ($400,000,000) on January 17, 2007 (the "Stated Maturity"), and to pay interest thereon from January 17, 2002 or from the most recent date to which
interest has been paid or duly provided for, semi-annually on July 17 and January 17 in each year (each, an "Interest Payment Date"), commencing July 17, 2002, and at
Maturity, at the rate of 5.20% per annum, until the principal hereof is paid or duly made available for payment. Interest on this Note shall be calculated on the basis of a 360-day year
consisting of twelve 30-day months. The interest so payable and punctually paid or duly provided for on any Interest Payment Date will, as provided in such Indenture, be paid to the Person
in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on the "Regular Record Date" for such interest, which shall be the July 2 or
January 2 (whether or not a Business Day, as hereinafter defined) next preceding each such Interest Payment Date. Any such interest which is payable, but is not punctually paid or duly provided
for, on any Interest Payment Date shall forthwith cease to be payable to the registered Holder hereof on the relevant Regular Record Date by virtue of having been such Holder, and may be paid
(i) to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to
be fixed by the Trustee, notice whereof shall be given to the Holder of this Note not less than 10 days prior to such Special Record Date or (ii) in any other lawful manner not
inconsistent with the requirements of any securities exchange on which this Note may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the
Trustee of the proposed payment pursuant to this clause (ii), such manner of payment shall be deemed practicable by the Trustee. In the event that a payment of principal or interest is due on a
date that is not a Business Day (as defined below), the related payment of principal or interest shall be made on the next succeeding Business Day with the 

 

same force and effect as if made on the date such payment was due, and no interest shall accrue on the amount so payable for the period from and after such Interest Payment Date or date of Maturity,
as the case may be. "Business Day" shall mean any day other than a Saturday, a Sunday or a legal holiday in The City of New York on which banking institutions are authorized or required by law,
regulation or executive order to close. 

        Payment
of the principal of and the interest on this Note will be made at the office or agency of the Company maintained for that purpose in The City of New York, in such coin or
currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided,  however, that, at the
option of the Company, interest may be paid by check mailed to the address of the Person entitled thereto as such address shall
appear in the Security Register. Payment of the principal of and interest on this Note due at Maturity will be made in immediately available funds upon presentation of this Note. 

        Reference
is hereby made to the further provisions of this Note set forth on the reverse side hereof, which further provisions shall for all purposes have the same effect as if set forth
at this place. 

        Unless
the certificate of authentication hereon has been executed by or on behalf of the Trustee under the Indenture by the manual signature of one of its authorized signatories, this
Note shall not be entitled to any benefits under the Indenture or be valid or obligatory for any purpose. 

        IN
WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

Dated:
January 17, 2002 

	 	UNITEDHEALTH GROUP

INCORPORATED
	

 	

By:	

	 	Name:	Patrick J. Erlandson
	 	Title:	Chief Financial Officer

	

 	

Attest:	

	 	Name:	David J. Lubben
	 	Title:	General Counsel and Secretary

	TRUSTEE'S CERTIFICATE OF

AUTHENTICATION	 	 
	

This is one of the Securities of the series designated herein and issued pursuant to the within-mentioned Indenture.	
 	

 
	

Dated: January 17, 2002	
 	

 
	
THE BANK OF NEW YORK,

as Trustee	
 	

 
	

By:	

	
 	

 
	 	Authorized Signatory

	 	 

UnitedHealth Group Incorporated

5.20% Notes due January 17, 2007  

2

 

[REVERSE SIDE OF NOTE] 

        This
Note is one of a duly authorized issue of securities of the Company (herein called the "Notes") issued and to be issued in one or more series under a senior debt securities
Indenture dated as of November 15, 1998, as amended by an Amendment to Indenture dated as of November 6, 2000, as further supplemented by an Officers' Certificate and Company Order dated
January 17, 2002 pursuant to Section 301 of the Indenture (herein called, the "Indenture") between the Company and The Bank of New York, as Trustee (herein called the "Trustee", which
term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of
rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Notes, and the terms upon which the Notes are, and are to be, authenticated and delivered. This Note is one
of the series designated on the face hereof, limited in initial aggregate principal amount to $400,000,000; provided, however, that the Company may, so long as no Event of Default has occurred and is
continuing, without the consent of the Holders of the Notes of this series, issue additional notes with the same terms as the Notes of this series, and such additional notes shall be considered part
of the same series under the Indenture as the Notes of this series. 

        The
Notes will not be entitled to any sinking fund. 

Redemption  

        The Notes are redeemable, in whole or in part at any time before the Stated Maturity, at the option of the Company at a Redemption Price equal to the greater of
(i) 100% of the principal amount of the Notes to be redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and interest on the Notes to be
redeemed (excluding the portion of any such interest accrued to the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year
consisting of twelve 30-day months) at the Treasury Yield (as defined below), plus 25 basis points, plus, in each case, accrued and unpaid interest to the Redemption Date. For this
purpose, the following terms have the following meanings: 

	•
	"Treasury
Yield" means, with respect to any Redemption Date, the rate per year equal to the semi-annual equivalent yield to maturity or
interpolated (on a day count basis) yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to
the Comparable Treasury Price for such Redemption Date.

	•
	"Comparable
Treasury Issue" means the United States Treasury security selected by an Independent Investment Banker appointed by the Trustee after
consultation with the Company as having an actual or interpolated maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes.

	•
	"Comparable
Treasury Price" means, with respect to any Redemption Date, (i) the average of the Reference Treasury Dealer Quotations for such
Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations for such Redemption Date, or (ii) if the Trustee obtains fewer than four such Reference
Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations.

	•
	"Independent
Investment Banker" means either Goldman, Sachs & Co. or Merrill Lynch, Pierce, Fenner & Smith Incorporated or their respective
successors or, if such firms are unwilling or unable to select the Comparable Treasury Issue, one of the remaining Reference Treasury Dealers appointed by the Trustee after consultation with the
Company. 

3

 

	•
	"Reference
Treasury Dealer" means (i) each of Goldman, Sachs & Co. and Merrill Lynch, Pierce, Fenner & Smith Incorporated or their
affiliates and any other primary U.S. Government securities dealer in New York City (a "Primary Treasury Dealer") designated by, and not affiliated with, either Goldman, Sachs & Co. or Merrill
Lynch, Pierce, Fenner & Smith Incorporated, provided, however, that if Goldman, Sachs &
Co. or Merrill Lynch, Pierce, Fenner & Smith Incorporated or any of their respective affiliates shall cease to be a Primary Treasury Dealer, the Company will appoint another Primary Treasury
Dealer as a substitute for such entity and (ii) any other Primary Treasury Dealer selected by the Trustee.

	•
	"Reference
Treasury Dealer Quotations" means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the
Trustee, of the bid and asked prices for the Comparable Treasury Issue (expressed, in each case, as a percentage of its principal amount) quoted in writing to the Trustee by such Reference Treasury
Dealer at 5:00 p.m. on the third business day preceding such Redemption Date. 

        A
notice of redemption may provide that it is subject to certain conditions that will be specified in the notice. If those conditions are not met, the redemption notice will be of no
effect and the Company will not be obligated to redeem this Note. 

        A
partial redemption of the Notes may be effected on a pro rata basis (and in such manner as complies with applicable legal and stock
exchange requirements, if any) or in such method as the Trustee, in the exercise of its reasonable discretion, deems fair and appropriate. The Trustee may provide for the selection for redemption of
portions in amounts of $1,000 or whole multiples of $1,000; except that if all of the Notes of a Holder are to be redeemed, the entire outstanding amount of Notes held by such Holder, even if not a
multiple of $1,000, shall be redeemed. 

        Notice
of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed. 

        Unless
any Note called for redemption shall not be paid upon surrender thereof for redemption, on and after the Redemption Date interest will cease to accrue on the Notes or portions
thereof called for redemption. 

Miscellaneous Provisions  

        If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due and payable in the manner and with
the effect provided in the Indenture. 

        The
Indenture contains provisions for defeasance at any time of the Company's obligations in respect of (i) the entire indebtedness of this Note or (ii) certain restrictive
covenants with respect to this Note, in each case upon compliance with certain conditions set forth therein. 

        The
Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
of the Securities of each series issued under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not less than a majority in aggregate principal amount of the
Securities of all series at the time Outstanding affected thereby. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the
Securities of any series at the time Outstanding to waive certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive
and binding upon such Holder and upon all future Holders of this Note and of any Notes issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation
of such consent or waiver is made upon this Note. 

4

 

        No
reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay
the principal of (and premium, if any) and interest on this Note, at the time, place and rate, and in the coin or currency, herein and in the Indenture prescribed. 

        As
provided in the Indenture and subject to certain limitations set forth therein and in this Note, the transfer of this Note is registrable in the registry books of the Company, upon
surrender of this Note for registration of transfer at the office or agency of the Company maintained for the purpose in any place where the principal of (and premium, if any) and interest on this
Note are payable, duly endorsed, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Trustee duly executed by the Holder hereof or by his attorney duly
authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

        The
Notes of this series are issuable only in fully registered form without coupons in minimal initial purchase amounts of $1,000 and any amount in excess thereafter which is an integral
multiple of $1,000. As provided in the Indenture and subject to certain limitations therein set forth, Notes of this series are exchangeable for a like aggregate principal amount of Notes of this
series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. 

        No
service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge
payable in connection therewith, other than in certain cases provided in the Indenture. 

        Prior
to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is
registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

        This
Note shall be governed by and construed in accordance with the laws of the State of New York. 

        All
capitalized terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. 

5

 

ABBREVIATIONS  

        The following abbreviations, when used in this instrument, shall be construed as though they were written out in full according to applicable laws or regulations: 

TEN
COM—as tenants in common

TEN ENT—as tenants by the entireties

JT TEN—as joint tenants with right of survivorship

                and not as tenants in common 

	UNIF GIFT MIN ACT—	 	
	 	Custodian	 	

	 	 	(Cust)	 	 	 	(Minor)
	

under Uniform Gift to Minors Act
	

 	
 	

	
 	

 	
 	

 
	 	 	(State)	 	 	 	 
	

Additional abbreviations may be used though not in the above list.	
 	

 	
 	

 
	

 	
 	

	
 	

 	
 	

 

6

 

        FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto 

PLEASE
INSERT SOCIAL SECURITY

OR OTHER IDENTIFYING NUMBER

OF ASSIGNEE 

	

 (Name and address of assignee, including zip code, must be printed or typewritten)
	

 the within Note, and all rights thereunder, hereby irrevocably constituting and appointing
	

 Attorney to transfer said Note on the books of the within Company, with full power of substitution in the premises
	

Dated	
 	

	
 	

	

 	
 	

 	
 	

        NOTICE: The signature on this assignment must correspond with the name as written upon the face of the within Note in every particular, without alteration or
enlargement or any change whatsoever. 

        SIGNATURE
GUARANTEE: Signatures must be guaranteed by an "eligible institution" meeting the requirements of the Security Registrar, which requirements include membership or participation
in the Security Transfer Agent Medallion Program ("STAMP") or such other "signature guarantee program" as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all
in accordance with the Securities Exchange Act of 1934, as amended. 

7

QuickLinks

Exhibit 4.2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]